In eukaryotic translation, eukaryotic initiation factors (eIFs) are at least as important as the ribosome itself. Some of these factors play different roles throughout the entire process to ensure proper assembly of the preinitiation complex on mRNA, accurate selection of the initiation codon, errorless production of the encoded polypeptide and its proper termination. Perhaps, the most important factor integrating signals from others and coordinating their functions on the ribosome is eIF3. In Saccharomyces cerevisiae, eIF3 is formed by five subunits. All these subunits contain structural motifs responsible for contact with ribosomal proteins and RNAs. In addition to these highly structured parts, the rest of eIF3 is unstructured and very flexible. Therefore, despite the recent progress thanks to the use of a cryo-electron microscopy, a precise structure and position of eIF3 on the 40S ribosomal subunit are still not known. Also, the presence of eIF3 on 80S during early elongation and its role in reinitiation and readthrough are not fully understood. In order to crack mysteries of yeast eIF3, we used x-ray crystallography, chemical cross- linking coupled to mass spectrometry, and various biochemical and genetic assays. We demonstrated that eIF3 is very compactly packed when free in solution. This...

There is currently very few information about the transaltion of linear cytoplasmatic plasmids occured in yeast cells Kluyveromyces lactis. However, there is a relatively well developer information about their transcription apparatus. A study of transkript linear plasmids revealed an atypical organization at the 5ʼ end. Those ends contain nontemplate polyadenylation and they are missing the N7 methylguanosine hat. Because of the presence of this structure, which is localized at 5ʼend of plasmids specific mRNA, raised a question regarding the iniciation of the translation. The present thesis is focused on the preparation of reporter systém suitable for studying the influence of a number of the nontemplate adenosins, which were added at the 5ʼ ends of mRNA linear plasmids. The frist step was making a construction of dual yeast cell plasmids carring two reporters genes, which are under the controle of two different promoters. After a successfull construction, the aktivity of promoters TEF1 and PGK1 was measured, whereby the promoter TEF1 proved twice stronger. The transcription start site of both promotor was determined. The second step was the construction of a reporter system directly in yeast cell plasmid pGKL. Reporter genes were under the controle of two promoters originating from the pGKL...

No description available.

Recombinant DNA technology has been commonly used in a number of fields to synthesize new products or generate products with a new pathway. Conventional cloning methods are expensive and require significant time and labor; λ-PCR, a new cloning method developed in the Senger lab, has a number of advantages compared to other cloning processes due to its employment of relatively inexpensive and widely available materials and time-efficiency. While the amount of lab work required for the cloning process is minimal, the importance of accurate primer design cannot be overstated. The target of this study was to create an effective procedure for λ-PCR primer design that ensures accurate cloning reactions. Additionally, synthetic ribosome binding sites (RBS) were included in the primer designs to test heterologous protein expression of the cyan fluorescent reporter with different RBS strengths. These RBS sequences were designed with an online tool, the RBS Calculator. A chimeric primer design procedure for λ-PCR was developed and shown to effectively create primers used for accurate cloning with λ-PCR; this method was used to design primers for CFP cloning in addition to two enzymes cloned in the Senger lab. A total of five strains of BL21(DE3) with pET28a + CFP were constructed, each with the same cyan fluorescent protein (CFP) reporter but different RBS sequences located directly upstream of the start codon of the CFP gene. Expression of the protein was measured using both whole-cell and cell-free systems to determine which system yields higher protein concentrations. A number of other factors were tested to optimize conditions for high protein expression, including: induction time, IPTG concentration, temperature, and media (for the cell-free experiments only). Additionally, expression for each synthetic RBS sequence was investigated to determine an accurate method for predicting protein translation. NUPACK and the Salis Lab RBS Calculator were both used to evaluate the effects of these different synthetic RBS sequences. The results of the plate reader experiments with the 5 CFP strains revealed a number of factors to be statistically significant when predicting protein expression, including: IPTG concentration, induction time, and in the cell-free experiments, type of media. The whole-cell system consistently produced higher amounts of protein than the cell-free system. Lastly, contrasts between the CFP strains showed each strain's performance did not match the predictions from the RBS Calculator. Consequently, a new method for improving protein expression with synthetic RBS sequences was developed using relationships between Gibbs free energy of the RBS-rRNA complex and expression levels obtained through experimentation. Additionally, secondary structure present at the RBS in the mRNA transcript was modeled with strain expression since these structures cause deviations in the relationship between Gibbs free energy of the mRNA-rRNA complex and CFP expression. / Master of Science / Recombinant DNA technology has been used to genetically enhance organisms to produce greater amounts of a product already made by the organism or to make an organism synthesize a new product. Genes are commonly modified in organisms using cloning practices which typically involves inserting a target gene into a plasmid and transforming the plasmid into the organism of interest. A new cloning process developed in the Senger lab, λ-PCR, improves the cloning process compared to other methods due to its use of relatively inexpensive materials and high efficiency. A primary goal of this study was to develop a procedure for λ-PCR primer design that allows for accurate use of the cloning method. Additionally, this study investigated the use of synthetic ribosome binding sites to control and improve expression of proteins cloned into an organism. Ribosome binding sites are sequences located upstream of the gene that increase the molecule’s affinity for the rRNA sequence on the ribosome, bind to the ribosome just upstream of the beginning of the gene, and initiate expression of the gene. Tools have been developed that create synthetic ribosome binding sites designed to produce specific amounts of protein. For example, the tools can increase or decrease expression of a gene depending on the application. These tools, the Salis Lab RBS Calculator and NUPACK, were used to design and evaluate the effects of the synthetic ribosome binding sites. Additionally, a new method was created to design synthetic ribosome binding sites since the methods used during the design process yielded inaccuracies. Each strain of E. coli contained the same gene, a cyan fluorescent protein (CFP), but had different RBS sequences located upstream of the gene. Expression of CFP was controlled via induction, meaning the addition of a particular molecule, IPTG in this system, triggered expression of CFP. Each of the CFP strains were tested with a variety of v conditions in order to find the conditions most suitable for protein expression; the variables tested include: induction time, IPTG (inducer) concentration, and temperature. Media was also tested for the cell-free systems, meaning the strains were grown overnight for 18 hours and lysed, a process where the cell membrane is broken in order to utilize the cell’s components for protein expression; the cell lysate was resuspended in new media for the experiments. ANOVA and multiple linear regression revealed IPTG concentration, induction time, and media to be significant factors impacting protein expression. This analysis also showed each CFP strain did not perform as the RBS Calculator predicted. Modeling each strain’s CFP expression using the RBS-rRNA binding strengths and secondary structures present in the RBS allowed for the creation of a new model for predicting and designing RBS sequences.

Hepatitis C virus (HCV) is a worldwide spread pathogen infecting up to 3 % of the human population. Nowadays, research of new drugs against this virus is focused on the individual steps in its life cycle, including the translation initiation. In the case of HCV translation initiation is dependent on the internal ribosome entry site (IRES). Besides of components of the translational machinery also other components of the cell, so called IRES trans-acting factors (ITAF), contribute to its proper progress. This work continues in previous research of our laboratory focused on searching for new ITAF. In order to search for potential ITAF increasing HCV IRES activity new recombinant plasmid vectors and reference strains were prepared and selection conditions of the selection system were optimized. The differences in the growth characteristics of the reference strains were analyzed and quantified under selective and non-selective conditions. A set of pilot high efficiency transformations of the yeast strain pJ69-4A carrying bicistronic construct with HCV IRES were conducted using human expression cDNA library in order to optimize the efficiency of transformation and selection conditions and to attempt to identify new ITAF. Several dozens of randomly selected clones from these transformations obtained under...

The ribosome is a macromolecular machine that produces proteins in all kingdoms of life. The proteins, in turn, control the biochemical processes within the cell. It is thus of extreme importance that the machine that makes the proteins works with high precision. By using three dimensional structures of the ribosome and homology modelling, we have applied molecular dynamics simulations and free-energy calculations to study the codon specificity of protein synthesis in initiation and termination on an atomistic level. In addition, we have examined the binding of small molecules to riboswitches, which can change the expression of an mRNA. The relative affinities on the ribosome between the eukaryotic initiator tRNA to the AUG start codon and six near-cognate codons were determined. The free-energy calculations show that the initiator tRNA has a strong preference for the start codon, but requires assistance from initiation factors 1 and 1A to uphold discrimination against near-cognate codons. When instead a stop codon (UAA, UGA or UAG) is positioned in the ribosomal A-site, a release factor binds and terminates protein synthesis by hydrolyzing the nascent peptide chain. However, vertebrate mitochondria have been thought to have four stop codons, namely AGA and AGG in addition to the standard UAA and UAG codons. Furthermore, two release factors have been identified, mtRF1 and mtRF1a. Free-energy calculations were used to determine if any of these two factors could bind to the two non-standard stop codons, and thereby terminate protein synthesis. Our calculations showed that the mtRF’s have similar stop codon specificity as bacterial RF1 and that it is highly unlikely that the mtRF’s are responsible for terminating at the AGA and AGG stop codons. The eukaryotic release factor 1, eRF1, on the other hand, can read all three stop codons singlehandedly. We show that eRF1 exerts a high discrimination against near-cognate codons, while having little preference for the different cognate stop codons. We also found an energetic mechanism for avoiding misreading of the UGG codon and could identify a conserved cluster of hydrophobic amino acids which prevents excessive solvent molecules to enter the codon binding site. The linear interaction energy method was used to examine binding of small molecules to the purine riboswitch and the FEP method was employed to explicitly calculate the LIE b-parameters. We show that the purine riboswitches have a remarkably high degree of electrostatic preorganization for their cognate ligands which is fundamental for discriminating against different purine analogs.

Les résistances génétiques permettent une lutte efficace contre les maladies des plantes cultivées mais sont limitées par les capacités d’évolution des bioagresseurs ciblés. Chez le piment, le fonds génétique peut améliorer la durabilité de la résistance au PVY conférée par le gène majeur pvr23. L’objectif de ma thèse était de caractériser les facteurs génétiques de l’hôte conditionnant la durabilité du gène majeur en répondant aux questions suivantes : (i) Quels sont leurs actions sur l’évolution des populations virales ? (ii) Correspondent-ils aux QTL (quantitative trait loci) de résistance partielle ? (iii) Sont-ils répandus au sein des ressources génétiques du piment ? Différentes expérimentations incluant des tests de résistances, d’évolution expérimentale et de compétition entre différents variants viraux, ont montré que les facteurs du fonds génétique augmentant la durabilité de pvr23 agissaient en : (i) diminuant la concentration virale dans la plante, (ii) en réduisant les probabilités de mutations du PVY vers le contournement du gène pvr23 et (iii) en ralentissant la sélection des variants viraux contournants. La détection de QTL et la cartographie des facteurs génétiques affectant la fréquence de contournement de pvr23 (QTL de durabilité) a mis en évidence quatre régions du génome du piment qui, par des effets additifs ou épistatiques, expliquent 70% de la variabilité phénotypique observée. La cartographie comparée montre que trois des quatre QTL de durabilité co-localisent avec des QTL affectant la résistance partielle, suggérant que les QTL de résistance partielle ont un effet pléiotropique sur la durabilité d’un gène majeur de résistance. L’étude d’une collection de 20 accessions de piment, porteuses de pvr23 ou pvr24(allèle très proche de pvr23) dans des fonds génétiques variés, a montré que les fonds génétiques favorables à la durabilité de ces allèles de résistance sont fréquents dans les ressources génétiques du piment. Ces résultats mettent en évidence que la durabilité d’un gène majeur de résistance peut-être fortement augmentée lorsqu’il est associé à des facteurs génétiques réduisant la multiplication du pathogène. De plus, la fréquence de contournement du gène majeur s’est révélée être un caractère très héritable (h²=0.87) et la détection de QTL affectant ce caractère est possible. La sélection directe pour de tels QTL est donc envisageable et ouvre de nouvelles perspectives pour préserver la durabilité des gènes majeurs de résistance utilisés en sélection variétale. / Genetic resistances provide an efficient control of crop diseases but are limited by pathogen adaptation.In pepper, the durability of the pvr23 allele, conferring resistance to Potato virus Y (PVY), was demonstrated todepend on the plant genetic background. The aim of my PhD thesis was to characterize the host genetic factorsaffecting the durability of the major resistance gene pvr23 and to answer to the following question s: (i) What istheir action on the evolution of the viral population? (ii) Is there identity between the QTLs (quantitative traitloci) controlling the partial resistance and the QTLs affecting the durability of pvr23? (iii) Are these genetic factorswidespread among the genetic resources of pepper? Various experiments including resistance testing,experimental evolution and competition between various PVY variants, enabled to show that the genetic factorsaffecting the durability of pvr23 acted in: (i) decreasing the viral accumulation, (ii) decreasing the probability ofacquisition of resistance breaking (RB) mutations by PVY and (iii) slowing down the selection of RB variants. QTLdetection and mapping of genetic factors affecting the frequency of pvr23 RB showed that four loci actingadditively and in epistatic interactions explained together 70% of the variance of pvr23 breakdown frequency.Comparative mapping between these QTLs and QTLs affecting partial resistance showed that three of the fourQTLs controlling the frequency of pvr23 RB are also involved in quantitative resistance, suggesting that QTLs forquantitative resistance have a pleiotropic effect on the durability of the major resistance gene. Analysis of acollection of 20 pepper accessions, carrying pvr23 or pvr24 (allele closely related to pvr23) in various geneticbackgrounds, showed that genetic backgrounds favorable to the durability of the pvr2-mediated resistance arewidespread in the genetic resources of pepper. These results highlight that the durability of a major resistancegene can be strongly increased when associated with genetic factors decreasing the pathogen multiplication.Moreover, the frequency of a major gene RB is a highly heritable trait and QTLs detection for this trait isachievable. The direct selection for such QTLs opens new prospects to preserve the durability of major resistancegenes used by breeders.

Eukaryotic translation initiation factor eIF4E1 (eIF4E1) plays a pivotal role in the control of cap-dependent translation initiation, occurs in P- bodies and is important for the formation of stress granules (SG). Human cells encompass two other non-canonical translation initiation factors capable of cap binding although with a lower affinity for the cap: eIF4E2 and eIF4E3. Here, I investigated the ability of individual eIF4E family members and their variants to localize to SGs and P-bodies in stress-free, arsenite and heat shock conditions. Under all tested conditions, both eIF4E1 and eIF4E2 proteins and all their variants localized to P-bodies unlike eIF4E3 protein variants. Under both arsenite and heat stress conditions all tested variants of eIF4E1 and the variant eIF4E3-A localized to SGs albeit with different abilities. Protein eIF4E2 and all its investigated variants localized specifically to a major part of heat stress-induced stress granules. Further analysis showed that approximately 75% of heat stress-induced stress granules contain all three eIF4Es, while in 25% of them eIF4E2 is missing. Large ribosomal subunit protein L22 was found specifically enriched in arsenite induced SGs. Heat stress-induced re- localization of several proteins typical for P-bodies such as eIF4E2, DCP-1, AGO-2...

Malgré les thérapies anti-cancéreuses ciblées, beaucoup de patients récidivent à cause de la résistance aux traitements qui constitue un problème clinique majeur. Cette résistance est soutenue par la reprogrammation métabolique et traductionnelle. La synthèse des protéines oncogéniques fait appel au complexe d’initiation de la traduction eucaryote 4F (eIF4F), compris des facteurs : eIF4A, eIF4E et eIF4G. Il est ainsi possible de cibler la synthèse protéique spécifique aux cellules cancéreuses par des inhibiteurs de l’initiation de la traduction. Nous proposons que le ciblage de la machinerie traductionnelle, via l’inhibition du eIF4A (eIF4Ai), affecte particulièrement les cellules cancéreuses. Mais est-ce qu’il est en mesure d’atténuer la résistance aux inhibiteurs de kinase (IKs) et d’en empêcher l’adaptation et la reprogrammation métabolique? L’efficacité des eIF4Ais est vérifiée par l’évaluation de la croissance et de la mort cellulaire (Annexine V) dans des cellules de mélanome, sensibles et résistantes aux IKs. Celle-ci est accompagnée de la réduction de la synthèse protéique évaluée par profilage polysomique, de la baisse des cibles de l'eIF4Ai (BCL-2, CDK4...) quantifiées par western-blots, d’un important stress bioénergétique mesuré par Seahorse et du contrôle des principales voies métaboliques analysées par GCMS. L’analyse du profilage polysomique, de l’ARNseq et du métabolome permettront de mettre en évidence les réseaux qui soutiennent l’efficacité des eIF4Ais et les mécanismes moléculaires sous-jacents à l’efficacité de cette thérapie. Ces derniers seront par la suite validés par des approches génétiques évaluant les principaux gènes et voies métaboliques qui y sont impliqués. Cette étude comblera de grosses lacunes dans les connaissances relatives aux mécanismes moléculaires qui soutiennent la résistance aux IKs afin d’améliorer leur efficacité en clinique. / Despite advances in research and development of targeted cancer therapies, many patients relapse due to treatment resistance. This is the case of melanoma resistant to BRAF inhibitors (BRAFi). 40-50% of melanoma cancer cells express the constitutively active oncoprotein BRAFV600E, leading to metabolic and translational reprogramming that is proposed to support resistance to cancer therapies. Studies have shown the importance of the eukaryotic translation initiation complex 4F (eIF4F), including factors: eIF4A, eIF4E and eIF4G, in the oncogenic proteins’ synthesis (e.g. growth factors, metabolic factors, etc.). The cancer cells translatome is distinct from the normal cells translatome. It is thus possible to target protein synthesis specific to cancer cells using molecules that inhibit translation initiation, the limiting phase in this process, affecting the cancer cells specifically. We propose that targeting the translational machinery via eIF4A inhibitors (eIF4Ai) would attenuate resistance to kinase inhibitors (KIs) and we seek to dissect the underlying molecular mechanisms. The efficacy of eIF4Ais in BRAFi sensitive and/or resistant melanoma is evaluated showing that eIF4Ais inhibit cell growth and induce melanoma cells death, using growth curves and FACS (Annexin_V). This is accompanied by a protein synthesis reduction, evaluated by polysome profiling showing a decrease in eIF4Ais treated cells and western-blots showing a decrease in translational targets of eIF4Ai (BCL-2, CDK4, etc.). A significant bioenergetic stress is measured by Seahorse and the control of the main metabolic pathways including glycolysis, TCA cycle and amino acids metabolism is analyzed by GCMS. Then the analysis of the translatome by polysome profiling and RNAseq and of the metabolome by GCMS/LCMS and Seahorse shed light on the translational networks that dictate metabolic reprogramming supporting eIF4Ai efficacy. Finally, the molecular mechanisms underlying the efficacy of eIF4Ai will be identified using genetic approaches to validate the main genes and metabolites and/or corresponding metabolic pathways involved in the response to eIF4Ai of the kinase inhibitor resistant melanoma. This study will fill large gaps in knowledge about the molecular mechanisms that support resistance to KIs in order to improve their clinical efficacy.

[ES] Las poliaminas son metabolitos esenciales para el crecimiento de las células eucariotas y su metabolismo está frecuentemente desregulado en cáncer. Una de las dianas moleculares de las poliaminas es el factor de elongación de la traducción eIF5A, una proteína esencial y conservada evolutivamente. eIF5A es la única proteína conocida que contiene el aminoácido hipusina, que deriva de la poliamina espermidina. En humanos existen dos isoformas, eIF5A1 y eIF5A2. EIF5A2 se encuentra en el cromosoma 3q26, una región frecuentemente amplificada en muchos tumores y que está altamente expresada en varios tipos de cáncer, incluyendo el cáncer de pulmón no microcítico (CPNM). eIF5A2 es esencial para el mantenimiento de la proliferación celular y su inhibición la suprime en algunos tumores. Recientemente se ha correlacionado la sobreexpresión de eIF5A2 con la invasión y como biomarcador de mal pronóstico en algunos cánceres, y se ha observado que eIF5A2 induce la transición epitelio-mesenquimal (EMT) en CPNM. La EMT es un proceso complejo y reversible que induce la diferenciación de las células epiteliales a células mesenquimales migrantes con capacidad de invasión. Numerosos estudios han demostrado que la EMT está relacionada con la progresión del cáncer, metástasis y mal pronóstico en tumores. Por tanto, la determinación de un método eficaz para inhibir la EMT en CPNM podría mejorar significativamente los tratamientos actuales. La naturaleza altamente selectiva de la hipusinación de eIF5A2 y su susceptibilidad a la inhibición farmacológica sugieren que eIF5A2 es una diana terapéutica muy atractiva. Actualmente, se dispone de un análogo de poliamina, GC7, que se utiliza para inhibir la hipusinación y se ha demostrado que frena el crecimiento de células cancerosas. El presente trabajo de tesis doctoral tiene como objetivo caracterizar el papel patológico de eIF5A2 en el desarrollo del CPNM. Para ello, hemos estudiado, mediante modificaciones genéticas por silenciamiento y sobreexpresión, el papel de eIF5A2 en la proliferación, motilidad e invasión celular utilizando líneas celulares de CPNM. Así mismo, se ha estudiado el efecto del inhibidor GC7 en líneas celulares de CPNM y modelos murinos para determinar si previene o revierte la EMT, y reduce la migración y la invasión de células de CPNM. Por último, se ha analizado la correlación entre la expresión de eIF5A2, las variables clínico-patológicas y la supervivencia de los pacientes en una colección de muestras de pacientes con CPNM. Los resultados obtenidos sugieren la existencia de una regulación entre las isoformas eIF5A1 y eIF5A2 para compensar la expresión de ambos homólogos. Además, nuestros datos apuntan a una coordinación temporal y posicional entre las vías de TGFß1 y eIF5A2 para impulsar la traducción de proteínas requerida para el reordenamiento del citoesqueleto y la motilidad de las células cancerosas invasivas. Hemos demostrado con modelos de ratón in vivo, que los tumores generados mediante xenotrasplante de células que sobreexpresan eIF5A2 tienen mayor capacidad invasiva. Finalmente, mostramos la existencia de una correlación positiva entre la expresión de eIF5A2 y el marcador de proliferación Ki67 en tejido de tumores de CPNM, y que la tasa de supervivencia es menor en aquellos pacientes que expresan niveles elevados de eIF5A2. Los resultados obtenidos en este trabajo confirman que eIF5A2 podría ser empleado como un biomarcador de mal pronóstico en CPNM y su inhibición farmacológica podría emplearse como una posible herramienta terapéutica, sola o en combinación con otros fármacos, en aquellos casos en los que eIF5A2 se encuentre sobreexpresado. / [CA] Les poliamines són metabòlits essencials per al creixement de les cèl·lules eucariotes i el seu metabolisme està frequentment desregulat en càncer. Una de les dianes moleculars de les poliamines és el factor d'elongació de la traducció eIF5A, una proteïna essencial i conservada evolutivament. eIF5A és l'única proteïna cel·lular coneguda que conté l'aminoàcid hipusina, que deriva de la poliamina espermidina. En humans hi ha dues isoformes, eIF5A1 i eIF5A2. EIF5A2 es troba al cromosoma 3q26, una regió freqüentment amplificada en molts tumors, i que està altament expressada en diferent tipus de càncer, incloent el càncer de pulmó no microcític (CPNM). eIF5A2 és essencial per al manteniment de la proliferació cel·lular i la seva inhibició la suprimeix en alguns tumors. Recentment s'ha correlacionat la sobreexpressió d'eIF5A2 amb la invasió i com a biomarcador de mal pronòstic a alguns càncers i s'ha observat que eIF5A2 indueix la transicició epiteli-mesenquima (EMT) en CPNM. L'EMT és un procés complex i reversible que indueix la diferenciació de les cèl·lules epitelials a cèl·lules mesenquimals migrants amb capacitat d'invasió. Nombrosos estudis han demostrat que l'EMT està relacionada amb la progressió del càncer, la metàstasi i el mal pronòstic en molts tumors. Per tant, la determinació d'un mètode eficaç per inhibir l'EMT a CPNM podria millorar significativament els règims dels tractaments actuals. La naturalesa altament selectiva de la hipusinació d'eIF5A2 i la susceptibilitat a la inhibició farmacològica fan d'aquesta proteina una diana terapèutica molt atractiva. Actualment, es disposa d'un anàleg de poliamina, anomenat GC7, que s'utilitza per inactivar la reacció d'hipusinació i s'ha demostrat que inhibeix el creixement de cèl·lules canceroses. Aquest treball de tesi doctoral té com a objectiu caracteritzar el paper patològic d'eIF5A2 en el desenvolupament del CPNM. Per això, hem estudiat, mitjançant modificacions genètiques per silenciament i sobreexpressió, el paper d'eIF5A2 en la proliferació, la motilitat i la invasió cel·lular utilitzant línies cel·lulars de càncer de pulmó. Així mateix, s'ha estudiat l'efecte de l'inhibidor GC7 en línies cel·lulars de CPNM i models murins per determinar si augmenta la quimiosensibilitat de les cèl·lules, prevé o reverteix l'EMT i redueix la migració i la invasió de cèl·lules de CPNM. Finalment, s'ha analitzat la correlació entre l'expressió d'eIF5A2, les variables clinicopatològiques i la supervivència dels pacients en una col·lecció de mostres de pacients amb CPNM. Els resultats obtinguts suggereixen que hi ha una regulació entre les isoformes eIF5A1 i eIF5A2 per compensar l'expressió dels dos homòlegs. A més, les nostres dades apunten a una coordinació temporal i posicional entre les vies de TGFß1 i eIF5A2 per impulsar la traducció requerida de proteïnes per als reordenaments del citosquelet i les característiques de motilitat de les cèl·lules canceroses invasives. Hem demostrat amb models de ratolí in vivo que els tumors generats mitjançant xenotrasplantament de cèl·lules que sobreexpressen eIF5A2 tenen més capacitat invasiva. Finalment, mostrem l'existència una correlació positiva entre l'expressió d'eIF5A2 i el marcador de proliferació Ki67 en teixit de tumors de CPNM, i que la taxa de supervivència és menor en aquells pacients que expressaven alts nivells d'eIF5A2. Els resultats obtinguts en aquest treball confirmen que eIF5A2 podria ser emprat com un biomarcador de mal pronòstic a CPNM i la seva inhibició farmacològica podria utilitzar-se com una possible eina terapèutica, sola o en combinació amb altres fàrmacs, en aquells casos en què eIF5A2 es trobe sobreexpressat. / [EN] Polyamines are essential metabolites for eukaryotic cells growth, and their metabolism is frequently deregulated in cancer. One of the molecular targets of polyamines is the translation elongation factor eIF5A, an essential and evolutionarily conserved protein. eIF5A is the only protein known that contains the amino acid hypusine, which is derived from the polyamine spermidine. In humans there are two isoforms, eIF5A1 and eIF5A2. EIF5A2 is located on chromosome 3q26, a region frequently amplified in different types of cancer, including non-small cell lung cancer (NSCLC). eIF5A2 is essential for the maintenance of cell proliferation and its inhibition suppresses it in many tumors. Recently, eIF5A2 overexpression has been correlated with invasion and as a biomarker of poor prognosis in some cancers, and it has been observed that eIF5A2 induces epithelial-mesenchymal transition (EMT) in NSCLC. EMT is a complex and reversible process that induces the differentiation of epithelial cells into migrant mesenchymal cells with invasive capacity. Numerous studies have shown that EMT is related to cancer progression, metastasis, and poor prognosis in many tumors. Therefore, the determination of an effective method to inhibit EMT in NSCLC could significantly improve current treatment regimens. The highly selective nature of eIF5A2 hypusination and its susceptibility to pharmacological inhibition make this process a very attractive therapeutic target. Currently, a polyamine analog, called GC7, is available and is used to inactivate the hypusination reaction and has been shown to inhibit cancer cell growth. The objective of this doctoral thesis is to characterize the pathological role of eIF5A2 in the development of NSCLC. For this, we have studied, through genetic alterations by silencing and overexpression, the role of eIF5A2 in cell proliferation, motility and invasion using lung cancer cell lines. Likewise, the effect of the GC7 inhibitor in NSCLC cell lines and murine models has been studied to determine if it increases the chemosensitivity of cells, prevents or reverses EMT, and reduces migration and invasion of NSCLC cells. Finally, the correlation between the expression of eIF5A2, clinicopathological variables and patient survival has been analyzed in a collection of samples from patients with NSCLC. The results obtained suggest the existence of a regulation between the eIF5A1 and eIF5A2 isoforms to compensate the expression of both homologues. Furthermore, our data point to a temporal and positional coordination between the TGFß1 and eIF5A2 pathways to drive the required translation of proteins for cytoskeletal rearrangements and motility characteristics of invasive cancer cells. We have demonstrated with in vivo mouse models that tumors generated by xenotransplantation of cells that overexpress eIF5A2 have a greater invasive capacity. Finally, we show the existence of a positive correlation between the expression of eIF5A2 and the proliferation marker Ki67 in NSCLC tumor tissue, and that the survival rate is lower in those patients who expressed high levels of eIF5A2. The results obtained in this work confirm that eIF5A2 could be used as a biomarker of poor prognosis in NSCLC and its pharmacological inhibition could be used as a possible therapeutic tool, alone or in combination with other drugs, in those cases in which eIF5A2 is found overexpressed. / Martínez Férriz, A. (2023). Funciones del factor de inicio de la traducción eucariota 5A2 en el cáncer de pulmón [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/193293